Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Indications/Uses

Unresectable or Metastatic Melanoma: YERVOY (ipilimumab) is indicated for the treatment of unresectable or metastatic melanoma.
Advanced Renal Cell Carcinoma: YERVOY, in combination with nivolumab, is indicated for the treatment of patients with intermediate or poor risk, previously untreated advanced renal cell carcinoma (RCC) [see PHARMACOLOGY: CLINICAL STUDIES: Previously Untreated Advanced Renal Cell Carcinoma under Actions].
Malignant Pleural Mesothelioma: YERVOY, in combination with nivolumab, is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma.

Yervoy Indications/Uses

ipilimumab

Manufacturer:

Bristol-Myers Squibb

Distributor:

DKSH

Marketer:

Bristol-Myers Squibb